Graph convolutional network for structural equivalent key nodes identification in complex networks
Asmita Patel,
No information about this author
Buddha Singh
No information about this author
Chaos Solitons & Fractals,
Journal Year:
2025,
Volume and Issue:
196, P. 116376 - 116376
Published: April 4, 2025
Language: Английский
GENEvaRX: A novel AI-driven method and web tool can identify critical genes and effective drugs for Lichen Planus
Engineering Applications of Artificial Intelligence,
Journal Year:
2023,
Volume and Issue:
124, P. 106607 - 106607
Published: July 4, 2023
Language: Английский
Identification of hub genes and potential molecular mechanisms related to drug sensitivity in acute myeloid leukemia based on machine learning
Boyu Zhang,
No information about this author
Haiyan Liu,
No information about this author
Fengxia Wu
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: April 8, 2024
Background:
Acute
myeloid
leukemia
(AML)
is
the
most
common
form
of
among
adults
and
characterized
by
uncontrolled
proliferation
clonal
expansion
hematopoietic
cells.
There
has
been
a
significant
improvement
in
treatment
younger
patients,
however,
prognosis
elderly
AML
patients
remains
poor.
Methods:
We
used
computational
methods
machine
learning
(ML)
techniques
to
identify
explore
differential
high-risk
genes
(DHRGs)
AML.
The
DHRGs
were
explored
through
multiple
silico
approaches
including
genomic
functional
analysis,
survival
immune
infiltration,
miRNA
co-expression
stemness
features
analyses
reveal
their
prognostic
importance
Furthermore,
using
different
ML
algorithms,
models
constructed
validated
DHRGs.
At
end
molecular
docking
studies
performed
potential
drug
candidates
targeting
selected
Results:
identified
total
80
comparing
differentially
expressed
derived
between
normal
controls
Cox
regression.
Genetic
epigenetic
alteration
revealed
association
copy
number
variations
methylation
status
with
overall
(OS)
patients.
Out
137
combination
Ridge
plsRcox
maintained
highest
mean
C-index
was
build
final
model.
When
classified
into
low-
groups
based
on
DHRGs,
low-risk
group
had
significantly
longer
OS
training
validation
cohorts.
coexpression,
feature
hallmark
pathway
differences
groups.
Drug
sensitivity
top
5
drugs,
carboplatin
austocystin-D
that
may
affect
Conclusion:
findings
from
current
study
set
be
as
therapeutic
markers
for
In
addition,
use
algorithms
constructing
validating
demonstrated.
Although
our
extensive
bioinformatics
hub
AML,
experimental
validations
knock-out/-in
would
strengthen
findings.
Language: Английский
maGENEgerZ: An Efficient Artificial Intelligence-Based Framework Can Extract More Expressed Genes and Biological Insights Underlying Breast Cancer Drug Response Mechanism
Mathematics,
Journal Year:
2024,
Volume and Issue:
12(10), P. 1536 - 1536
Published: May 15, 2024
Understanding
breast
cancer
drug
response
mechanisms
can
play
a
crucial
role
in
improving
treatment
outcomes
and
survival
rates.
Existing
bioinformatics-based
approaches
are
far
from
perfect
do
not
adopt
computational
methods
based
on
advanced
artificial
intelligence
concepts.
Therefore,
we
introduce
novel
framework
an
efficient
support
vector
machine
(esvm)
working
as
follows:
First,
downloaded
processed
three
gene
expression
datasets
related
to
responding
non-responding
treatments
the
omnibus
(GEO)
according
following
GEO
accession
numbers:
GSE130787,
GSE140494,
GSE196093.
Our
method
esvm
is
formulated
constrained
optimization
problem
its
dual
form
function
of
λ.
We
recover
importance
each
λ,
y,
x.
Then,
select
p
genes
out
n,
which
provided
input
enrichment
analysis
tools,
Enrichr
Metascape.
Compared
existing
baseline
methods,
including
deep
learning,
results
demonstrate
superiority
efficiency
esvm,
achieving
high-performance
having
more
expressed
well-established
cell
lines,
MD-MB231,
MCF7,
HS578T.
Moreover,
able
identify
(1)
various
drugs,
clinically
approved
ones
(e.g.,
tamoxifen
erlotinib);
(2)
seventy-four
unique
(including
tumor
suppression
such
TP53
BRCA1);
(3)
thirty-six
TFs
SP1
RELA).
These
have
been
reported
be
linked
mechanisms,
progression,
metastasizing.
available
publicly
maGENEgerZ
web
server.
Language: Английский
GENEvaRX: A Novel AI-Driven Method and Web Tool Can Identify Critical Genes and Effective Drugs for Lichen Planus
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Feb. 24, 2023
Abstract
Lichen
planus
(LP)
is
an
autoimmune
disorder
diagnosed
based
on
physical
symptoms
and
lab
tests.
Examples
of
include
flat
bumps,
itchy
purplish
skin,
while
tests
a
shave
biopsy
the
lesion.
When
pathology
report
shows
consistency
with
LP
negative
for
potential
triggers
allergy
test
hepatitis
C,
dermatologist
typically
prescribes
corticosteroid
in
form
pills
or
injection
into
lesion
to
treat
symptoms.
To
understand
molecular
mechanism
disease
thereby
overcome
issues
associated
treatment,
there
need
identify
effective
drugs,
drug
targets,
therapeutic
targets
LP.
Hence,
we
propose
novel
computational
framework
new
constrained
optimization
support
vector
machines
coupled
enrichment
analysis.
First,
downloaded
three
gene
expression
datasets
(GSE63741,
GSE193351,
GSE52130)
pertaining
healthy
patients
from
omnibus
(GEO)
database.
We
then
processed
each
dataset
entered
it
our
select
important
genes.
Finally,
performed
analysis
selected
genes,
reporting
following
results.
Our
methods
outperformed
baseline
terms
identifying
skin
tissue.
Moreover,
5
drugs
(including,
dexamethasone,
retinoic
acid,
quercetin),
45
unique
genes
(including
PSMB8,
KRT31,
KRT16,
KRT19,
KRT17,
COL3A1,
LCE2D,
LCE2A),
23
TFs
NFKB1,
STAT1,
STAT3)
reportedly
related
pathogenesis,
treatments,
targets.
are
publicly
available
GENEvaRX
web
server
at
https://aibio.shinyapps.io/GENEvaRX/
.
Language: Английский
An Investigation of Complex Interactions Between Genetically Determined Protein Expression and the Metabolic Phenotype of Human Islet Cells Using Deep Learning
K. Padmaja,
No information about this author
Mukhopadhyay Debarka
No information about this author
SN Computer Science,
Journal Year:
2023,
Volume and Issue:
4(6)
Published: Oct. 6, 2023
Language: Английский
maGENEgerZ: An Efficient AI-Based Framework Can Extract More Expressed Genes and Biological Insights Underlying Breast Cancer Drug Response Mechanism
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 30, 2023
Abstract
Understanding
breast
cancer
drug
response
mechanism
can
play
a
crucial
role
in
improving
the
treatment
outcomes
and
survival
rates.
Existing
bioinformatics-based
approaches
are
far
from
perfect
do
not
adopt
computational
methods
based
on
advanced
artificial
intelligence
concepts.
Therefore,
we
introduce
novel
framework
an
efficient
support
vector
machines
(esvm)
working
as
follows.
First,
downloaded
processed
three
gene
expression
datasets
related
to
responding
non-responding
treatments
omnibus
(GEO)
according
following
GEO
accession
numbers:
GSE130787,
GSE140494,
GSE196093.
Our
method
esvm
is
formulated
constrained
optimization
problem
dual
form
function
of
λ.
We
recover
importance
each
λ,
y,
x.
Then,
select
p
genes
out
n,
provided
input
enrichment
analysis
tools,
Enrichr
Metascape.
Compared
existing
baseline
including
deep
learning,
results
demonstrate
superiority
efficiency
achieving
high
performance
having
more
expressed
well-established
cell
lines
MD-MB231,
MCF7,
HS578T.
Moreover,
able
identify
(1)
various
drugs
clinically
approved
ones
(e.g.,
tamoxifen
erlotinib);
(2)
seventy-four
unique
(including
tumor
suppression
such
TP53
BRCA1);
(3)
thirty-six
TFs
SP1
RELA).
These
have
been
reported
be
linked
mechanism,
progression,
metastasizing.
available
publicly
maGENEgerZ
web
server
at
https://aibio.shinyapps.io/maGENEgerZ/
.
Language: Английский